Skip to main content
NIH funding notice PAR-18-638

Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional)

Closed on June 13, 2019.

Posted
February 7, 2018
Close date
June 13, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,601,192 in first-year total cost, median $532,090.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 RPHB-R (56)]3

Most frequent institutions

  1. DREXEL UNIVERSITY1
  2. UNIVERSITY OF PENNSYLVANIA1
  3. VANDERBILT UNIVERSITY MEDICAL CENTER1
Competing awards under PAR-18-638 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Prediction of Anti-Cancer Medication Discontinuation via Patient Portal Messages and Structured Electronic Medical Records1R37CA237452-01A1YIN, ZHIJUNVANDERBILT UNIVERSITY MEDICAL CENTER, TN$402,913ZRG1
2019Cancer prevention through neural and geospatial examination of tobacco marketing effects in smokers1R01CA229305-01A1FALK, EMILYUNIVERSITY OF PENNSYLVANIA, PA$666,189ZRG1
2019Hashtag HPV: Engaging parents through social media to increase HPV vaccination1R01CA229324-01A1MASSEY, PHILIP MDREXEL UNIVERSITY, PA$532,090ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-638: Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional) | ScienceDex | ConductScience